BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

796 related articles for article (PubMed ID: 20334907)

  • 1. New antiarrhythmic drugs for treatment of atrial fibrillation.
    Dobrev D; Nattel S
    Lancet; 2010 Apr; 375(9721):1212-23. PubMed ID: 20334907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New antiarrhythmic drugs for treatment of atrial fibrillation].
    Raatikainen MJ; Huikuri HV
    Duodecim; 2010; 126(19):2255-62. PubMed ID: 21086684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmaceutical pipeline for atrial fibrillation.
    Santangeli P; Di Biase L; Pelargonio G; Burkhardt JD; Natale A
    Ann Med; 2011 Feb; 43(1):13-32. PubMed ID: 21166558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New antiarrhythmic drugs for atrial fibrillation: focus on dronedarone and vernakalant.
    Camm AJ; Savelieva I
    J Interv Card Electrophysiol; 2008 Oct; 23(1):7-14. PubMed ID: 18523740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New anthyarrhythmic drugs for atrial fibrillation.
    Matassini MV; Guerra F; Scappini L; Urbinati A; Capucci A
    Future Cardiol; 2015; 11(6):705-17. PubMed ID: 26631497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial-selective pharmacological therapy for atrial fibrillation: hype or hope?
    Ehrlich JR; Nattel S
    Curr Opin Cardiol; 2009 Jan; 24(1):50-5. PubMed ID: 19077816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New developments in the antiarrhythmic therapy of atrial fibrillation].
    Simon H; Simon Demel K; Ritscher G; Turschner O; Brachmann J
    Herzschrittmacherther Elektrophysiol; 2010 Dec; 21(4):212-6. PubMed ID: 21107985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the treatment of atrial fibrillation.
    Miranda RI; Simpson CS; Michael KA; Abdollah H; Baranchuk AM; Redfearn DP
    Minerva Cardioangiol; 2010 Dec; 58(6):637-48. PubMed ID: 21135805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New horizons in antiarrhythmic therapy: will novel agents overcome current deficits?
    Conway E; Musco S; Kowey PR
    Am J Cardiol; 2008 Sep; 102(6A):12H-19H. PubMed ID: 18790110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new antiarrhythmic drug in the treatment of recent-onset atrial fibrillation: vernakalant.
    Vizzardi E; Salghetti F; Bonadei I; Gelsomino S; Lorusso R; D'Aloia A; Curnis A
    Cardiovasc Ther; 2013 Oct; 31(5):e55-62. PubMed ID: 23398692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New antiarrhythmic drugs for the treatment of atrial fibrillation].
    Botto GL; Russo G; Mariconti B; Pentimalli F; Campana C
    G Ital Cardiol (Rome); 2012 Oct; 13(10 Suppl 2):10S-15S. PubMed ID: 23096368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vernakalant: pharmacology electrophysiology, safety and efficacy.
    Naccarelli GV; Wolbrette DL; Samii S; Banchs JE; Penny-Peterson E; Stevenson R; Gonzalez MD
    Drugs Today (Barc); 2008 May; 44(5):325-9. PubMed ID: 18548135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vernakalant: a novel antiarrhythmic drug for the rapid conversion of atrial fibrillation to sinus rhythm].
    Hirt MN; Eschenhagen T
    Dtsch Med Wochenschr; 2010 May; 135(19):971-6. PubMed ID: 20446233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New antiarrhythmic agents for atrial fibrillation and atrial flutter.
    Pecini R; Elming H; Pedersen OD; Torp-Pedersen C
    Expert Opin Emerg Drugs; 2005 May; 10(2):311-22. PubMed ID: 15934869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmenting maintenance of sinus rhythm in the control of atrial fibrillation by antiarrhythmic drug combinations.
    Singh BN
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):31S-5S. PubMed ID: 21098417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New developments in the antiarrhythmic therapy of atrial fibrillation].
    Ravens U
    Herzschrittmacherther Elektrophysiol; 2014 Mar; 25(1):41-6. PubMed ID: 24496483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vernakalant hydrochloride for the treatment of atrial fibrillation.
    Kozlowski D; Budrejko S; Lip GY; Mikhailidis DP; Rysz J; Raczak G; Banach M
    Expert Opin Investig Drugs; 2009 Dec; 18(12):1929-37. PubMed ID: 19938903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel anti-arrhythmic medications in the treatment of atrial fibrillation.
    Saklani P; Skanes A
    Curr Cardiol Rev; 2012 Nov; 8(4):302-9. PubMed ID: 22920483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dronedarone: a novel antiarrhythmic agent for the treatment of atrial fibrillation.
    Duray GZ; Ehrlich JR; Hohnloser SH
    Curr Opin Cardiol; 2010 Jan; 25(1):53-8. PubMed ID: 19881340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vernakalant. Too dangerous in atrial fibrillation.
    Prescrire Int; 2012 May; 21(127):119-22. PubMed ID: 22827000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.